Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending
Portfolio Pulse from Benzinga Newsdesk
Trading on Eiger BioPharmaceuticals, Inc. (EIGR) was halted at 7:50:00 p.m. ET due to pending news. The halt is in place to ensure a fair and orderly market until the pending news is released to the public.
January 06, 2024 | 12:50 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Eiger BioPharmaceuticals, Inc.'s stock trading has been halted pending news, which may indicate significant upcoming information that could impact the company's stock price.
Trading halts are typically enacted in anticipation of news that is expected to have a substantial effect on a company's stock price. The nature of the news is not disclosed, so the direction of the impact cannot be determined. However, the halt itself suggests that the news is material, and thus the importance and relevance are high. The confidence score is not at the maximum because the content and implications of the pending news are unknown.
CONFIDENCE 80
IMPORTANCE 100
RELEVANCE 100